Press Release: Sanofi Q1 - MarketScreener : vimarsana.com

Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance Paris, April 25, 2024 Sales growth of 6.7% at CER and business EPS of €1.78 Dupixent sales up 24.9% to €2,835...

Related Keywords

Paris , France General , France , Japan , Paul Hudson , Sanofi Global Health Unit , Mental Wellness , Digestive Wellness , Social Responsibility , Global Health Unit , Chief Executive Officer , Markets ,